Global Home Blood Collection and Micro-Sampling Devices Market 2021-2030: By Blood Sample Condition Type, Sample Collection Method, Device Usage, Scope and Geographical Regions | News

DUBLIN, 23 December 2021 / PRNewswire / – The report “At-Home Blood Collection and Micro Sampling Devices Industry Trends and Global Forecasts 2021-2030” has been added to ResearchAndMarkets.com offer.

After the start of the COVID-19 pandemic, there has been a drop in the number of patients visiting laboratories for sample collection and testing. Due to the infectious risk associated with such places, several patients have postponed their routine examinations and medical visits, in order to avoid the spread of the disease. In fact, an average drop of about 40% in phlebotomy appointments has been reported by various laboratories around the world.

The aforementioned concerns have encouraged stakeholders to develop new devices and technologies that can allow patients to take their own blood samples at home, to monitor their health remotely. More than 80% of the self-blood collection devices that we encountered during our research have already received marketing authorization.

In 2021, the TAP II and Tasso-M20 self-blood collection devices received CE marking from the European Commission. Additionally, recently Symbiotica received emergency use clearance from the USFDA for its proprietary COVID-19 home serology test kit, which has been shown to be able to detect the presence of SARS-CoV-2. using samples of dried blood drops.

The home blood collection and micro-sampling devices market is fragmented, with a mix of start-ups / small businesses and mid-size companies. Interestingly, more than 40% of start-ups engaged in this field have been established since 2014.

In addition, large companies are actively acquiring players in the small industry in order to either consolidate their existing capacities or to enter this niche field. As a result, there has been a significant increase in partnering activity related to home blood collection devices in recent years. In addition, public and private investors have invested more than $ 640 million in this field since 2014.

In view of the growing adoption and preference for home blood collection and self-collection approaches, coupled with the continued efforts of device developers and manufacturers to further expand their respective offerings, the collection device market home blood sampling and micro-sampling is expected to experience significant growth in the future.

The report includes:

  • A detailed overview of the current Home Self-Blood Collection and Micro-Sampling Devices market landscape, along with information on several relevant parameters. In addition, it presents details of the companies engaged in the development of home blood collection and micro-sampling devices, as well as information on their respective year of establishment, company size, location of headquarters. social and the most active actors.
  • Profiles of the main players, presenting a brief overview of the company, as well as information on the year of establishment, location of the head office, number of employees, key executives, product portfolio, recent developments and enlightened prospects for the future.
  • In-depth analysis of the product competitiveness of home blood collection and micro-sampling devices on the basis of several relevant parameters, such as the power of the supplier and the key specifications related to the products.
  • A detailed analysis of various patents that have been filed / granted in this field, since 2015. The analysis assesses several relevant parameters associated with patents, including type of patent, year of publication, regional applicability, symbols CPC, emerging areas of interest, the most active players and patent valuation.
  • An analysis of recent partnerships forged between the various actors involved in this field, during the period 2014-2021, on the basis of several relevant parameters, such as the year of partnership, the type of partnership model adopted, the field intervention, therapeutic area and regional distribution.
  • A detailed analysis of the different investments made by the actors engaged in this field, on the basis of several relevant parameters, such as the year of investment, the number of funding bodies, the amount invested and the type of funding, as well as information on the most active players, the most active investors, geographical distribution, object of the investment and field of application.
  • An insightful review highlighting the cost saving potential associated with home self-collection and micro-sampling devices, taking into account several relevant parameters.

Answers to key questions

  • Who are the main players involved in the development of self-blood collection and home micro-sampling devices?
  • What are the most popular home self-blood collection and micro-sampling devices available on the market?
  • What types of partnership models are commonly adopted by stakeholders in this industry?
  • Who are the main investors who have actively invested in this area?
  • How is the intellectual property landscape in this area likely to evolve in the foreseeable future?
  • How competitive are the different home blood collection and micro-sampling devices?
  • How much cost can you save by using home blood collection and micro-sampling devices?
  • How are current and future market opportunities likely to be distributed among key market segments?

COMPANY PROFILES

  • EUROIMMUN
  • Everlywell
  • Labcorp
  • Labonovum
  • Lameditech
  • Quest Diagnosis
  • Science spot
  • Cup
  • Weavr Health
  • YourBio Health

For more information on this report, visit https://www.researchandmarkets.com/r/2salaf

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Research and markets

Laura Wood, senior

[email protected]

For EST office hours, call + 1-917-300-0470

For USA / CAN call toll free + 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904

Fax (outside the United States): + 353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/global-at-home-blood-collection-and-micro-sampling-devices-market-2021-2030-by-type-of-blood – sample-state-method-of-sample-collection-device-use-zone-of-application-and-geographical-regions-301450316.html

SOURCE Research and Markets

Comments are closed.